Dexmedetomidine Infusion Impact on Chronic Pain Patients
NCT06402019
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Chronic Pain
Interventions
DRUG:
Dexmedetomidine in 0.9 % NaCl 20 Mcg/5 mL (4 Mcg/mL) INTRAVEN SYRINGE (ML)
DRUG:
normal saline
Sponsor
Benha University